Who Paid My Doc
Clinical Trial Product
Device Clinical Trial Product
General payments
$3,456,331
Research payments
$79,308,677
Through program year 2022, $3,456,331 in general payments and $79,308,677 in research payments were reported against Clinical Trial Product (Clinical Trial Product).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | General | $1,067,581 | 769 |
| 2022 | Research | $24,064,526 | 4,153 |
| 2021 | General | $788,699 | 539 |
| 2021 | Research | $19,815,266 | 2,336 |
| 2020 | General | $872,027 | 855 |
| 2020 | Research | $19,010,094 | 4,863 |
| 2019 | General | $728,024 | 808 |
| 2019 | Research | $16,418,790 | 5,684 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.
The top 5 of 22 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
The top 5 of 25 states; each share is of general payments naming this product in 2022 where a state was reported.
Records
2,971 general · 17,036 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.